mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
SGC0946 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
AZD-7545 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |